✦ LIBER ✦

Serious adverse events with low-dose, long-term corticosteroid therapy in rheumatoid arthritis

✍ Scribed by Lionel Roger

Book ID: 117016962
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 290 KB
Volume: 99
Category: Article
ISSN: 1555-7162
DOI: 10.1016/s0002-9343(99)80264-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-dose corticosteroid therapy in rheum

Low-dose corticosteroid therapy in rheumatoid arthritis: Balancing the evidence

✍ Kenneth G. Saag 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 907 KB

Long-term experience with low dose metho

Long-term experience with low dose methotrexate in rheumatoid arthritis

✍ M. Tishler; D. Caspi; M. Yaron 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 379 KB

Poor long-term results from low-dose met

Poor long-term results from low-dose methotrexate therapy in rheumatoid arthritis

✍ Oliver Fitzgerald; John Hanly; Jack Molony; Barry Bresnihan 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 2 views

Dose refinements in long-term therapy of

Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials

✍ Allen H. Mackenzie 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 658 KB

Folate status of rheumatoid arthritis pa

Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy

✍ Sarah L. Morgan; Joseph E. Baggott; Mary Altz-Smith 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 786 KB

The folate status of 29 healthy control subjects, 16 rheumatoid arthritis (RA) patients taking methotrexate (MTX), and 20 RA patients who were not being treated with MTX was estimated by an assay of the folate-dependent enzymatic synthesis of serine from formate and glycine, which is termed the C1 i

Long-term prospective trial of low-dose

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

✍ Michael E. Weinblatt; David E. Trentham; Patricia A. Fraser; Donald E. Holdswort 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 806 KB